Candida endocarditis associated with cardiac rhythm management devices: Review with current treatment guidelines

Mycoses

Volumn 54, Issue 4, 2011, Pages

  Halawa, Ahmad ^a   Henry, Philip D ^a   Sarubbi, Felix A ^a  

^a East Tennessee State University   (United States)

Author keywords

Candida; Cardioverter defibrillator; Endocarditis; Pacemaker

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; POSACONAZOLE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CANDIDA ALBICANS; CANDIDA ENDOCARDITIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CAUSE OF DEATH; CLINICAL ARTICLE; DEFIBRILLATOR; DEVICE INFECTION; DEVICE REMOVAL; HEART RHYTHM; HUMAN; MALE; MONOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RARE DISEASE; STAPHYLOCOCCUS EPIDERMIDIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; ENDOCARDITIS; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

CANDIDA; CANDIDA ALBICANS;

EID: 79959216972     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.01866.x     Document Type: Article

References (29)

1. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006; 48: 590-1.
2. Sohail MR, Uslan DZ, Khan AH et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc 2008; 83: 46-53.
3. Gil P, Fernández-Guerrero ML, Bayona JF et al. Infections of implantable cardioverter-defibrillators: frequency, predisposing factors and clinical significance. Clin Microbiol Infect 2006; 12: 533-7.
4. Klug D, Balde M, Pavin D et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007; 116: 1349-55.
5. Massoure PL, Reuter S, Lafitte S et al. Pacemaker endocarditis: clinical features and management of 60 consecutive cases. PACE 2007; 30: 12-19.
6. Uslan DZ, Sohail MR, St. Sauver JL et al. Permanent pacemaker and implantable cardioverter defibrillator infection. Arch Intern Med 2007; 167: 669-75.
7. Sohail MR, Uslan DZ, Khan AH et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007; 49: 1851-9.
8. Rundstrom H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18years in Göteborg. Scand J Infect Dis 2004; 36: 674-9.
9. Klug D, Lacroix D, Savoye C et al. Systemic infection related to endocarditis on pacemaker leads. Circulation 1997; 95: 2098-107.
10. Ho ICK, Milan DJ, Mansour MC et al. Fungal infection of implantable cardioverter-defibrillators: case series of five patients managed over 22years. Heart Rhythm 2006; 3: 919-23.
11. Wilson HA, Downes TR, Julian JS, White WL, Haponik EF. Candida endocarditis: a treatable form of pacemaker infection. Chest 1993; 103: 283-4.
12. Joly V, Belmatoug N, Leperre A et al. Pacemaker endocarditis due to Candida albicans: case report and review. Clin Infect Dis 1997; 25: 1359-62.
13. Kurup A, Janardhan MN, Seng TY. Candida tropicalis pacemaker endocarditis. J Infect 2000; 41: 275-6.
14. Arber N, Pras E, Copperman Y et al. Pacemaker endocarditis. Medicine 1994; 73: 299-305.
15. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35.
16. Roger PM, Boissy C, Gari-Toussaint M et al. Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata. J Infect 2000; 41: 176-8.
17. Cacoub P, Leprince P, Nataf P et al. Pacemaker infective endocarditis. Am J Cardiol 1998; 82: 480-4.
18. Davis JM, Moss AJ, Schenk EA. Tricuspid Candida endocarditis complicating a permanently implanted transvenous pacemaker. Am Heart J 1969; 77: 818-21.
19. Falcone M, Barzaghi N, Carosi G et al. Candida infective endocarditis: report of 15 cases from a prospective multicenter study. Medicine 2009; 88: 160-8.
20. del Río A, Anguera I, Miró JM et al. Surgical treatment of pacemaker and defibrillator lead endocarditis. The impact of electrode lead extraction on outcome. Chest 2003; 124: 1451-9.
21. de Oliveira JC, Martinelli M, Nishioka SAD et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators. Circ Arrhyth Electrophysiol 2009; 2: 29-34.
22. Brown LA, Baddley JW, Sanchez JE, Bachmann LH. Implantable cardioverter-defibrillator endocarditis secondary to Candida albicans. Am J Med Sci 2001; 322: 160-2.
23. Hindupur S, Muslin AJ. Septic shock induced from an implantable cardioverter-defibrillator lead-associated Candida albicans vegetation. J Interv Card Electrophysiol 2005; 14: 55-9.
24. Talarmin JP, Boutoille D, Tattevin P et al. Candida endocarditis: role of new antifungal agents. Mycoses 2009; 52: 60-6.
25. Victor F, De Place C, Camus C et al. Pacemaker lead infection: echocardiographic features, management and outcome. Heart 1999; 81: 82-7.
26. Ruttmann E, Hangler HB, Kilo J et al. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. PACE 2006; 29: 231-6.
27. Meier-Ewert HK, Gray ME, John RM. Endocardial pacemaker or defibrillator leads with infected vegetations: a single center experience and consequences of transvenous extraction. Am Heart J 2003; 146: 339-44.
28. Cole WJ, Slater J, Kronzon I et al. Candida albicans-infected transvenous pacemaker wire: detection by two-dimensional echocardiography. Am Heart J 1986; 111: 417-18.
29. Shmuely H, Kremer I, Sagie A, Pitlik S. Candida tropicalis multifocal endophthalmitis as the only initial manifestation of pacemaker endocarditis. Am J Ophthalmol 1997; 123: 559-60.